Bilcare Limited

BSE:526853 Stock Report

Market Cap: ₹1.3b

Bilcare Valuation

Is 526853 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 526853 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 526853 (₹53.81) is trading below our estimate of fair value (₹2254.79)

Significantly Below Fair Value: 526853 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 526853?

Key metric: As 526853 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 526853. This is calculated by dividing 526853's market cap by their current revenue.
What is 526853's PS Ratio?
PS Ratio0.2x
Sales₹7.71b
Market Cap₹1.29b

Price to Sales Ratio vs Peers

How does 526853's PS Ratio compare to its peers?

The above table shows the PS ratio for 526853 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3.3x
511509 Vivo Bio Tech
1.1xn/a₹595.8m
538837 Jeevan Scientific Technology
1.8xn/a₹823.4m
BROOKS Brooks Laboratories
4.7xn/a₹3.7b
540729 Vanta Bioscience
5.7xn/a₹259.2m
526853 Bilcare
0.2xn/a₹1.3b

Price-To-Sales vs Peers: 526853 is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (3.3x).

Price to Sales Ratio vs Industry

How does 526853's PS Ratio compare vs other companies in the Asian Life Sciences Industry?

9 CompaniesPrice / SalesEstimated GrowthMarket Cap
Industry Avg.4.4x16.1%
526853 Bilcare
 0.2xn/aUS$15.23m
526853 0.2xIndustry Avg. 4.4xNo. of Companies14PS03.26.49.612.816+
9 CompaniesEstimated GrowthMarket Cap
Industry Avg.4.4x22.8%
526853 Bilcare
 0.2xn/aUS$15.23m
No more companies

Price-To-Sales vs Industry: 526853 is good value based on its Price-To-Sales Ratio (0.2x) compared to the Asian Life Sciences industry average (4.4x).

Price to Sales Ratio vs Fair Ratio

What is 526853's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

526853 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.2x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 526853's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Caplin Point Laboratories

₹148.3b

Engages in the development, production, marketing, and export of generic pharmaceutical formulations and branded products in India.

CAPLIPOINT

₹1,952.15

7D

-0.09%

1Y

60.0%

Bal Pharma

₹2.1b

Manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally.

BALPHARMA

₹130.88

7D

14.0%

1Y

21.4%

Vilin Bio Med

₹313.9m

Engages in the manufacture and sale of pharmaceutical products in India.

VILINBIO

₹22.50

7D

-4.9%

1Y

6.1%